What is the share price of Godavari Biorefineries Ltd (GODAVARIB) today?
The share price of GODAVARIB as on 5th December 2025 is ₹237.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Godavari Biorefineries Ltd (GODAVARIB) share?
The past returns of Godavari Biorefineries Ltd (GODAVARIB) share are- Past 1 week: -5.32%
- Past 1 month: -9.79%
- Past 3 months: -12.74%
- Past 6 months: -14.13%
- Past 1 year: -34.81%
- Past 3 years: N/A%
- Past 5 years: -30.40%
What are the peers or stocks similar to Godavari Biorefineries Ltd (GODAVARIB)?
The peers or stocks similar to Godavari Biorefineries Ltd (GODAVARIB) include:What is the market cap of Godavari Biorefineries Ltd (GODAVARIB) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Godavari Biorefineries Ltd (GODAVARIB) is ₹1222.39 Cr as of 5th December 2025.What is the 52 week high and low of Godavari Biorefineries Ltd (GODAVARIB) share?
The 52-week high of Godavari Biorefineries Ltd (GODAVARIB) is ₹408.60 and the 52-week low is ₹145.What is the PE and PB ratio of Godavari Biorefineries Ltd (GODAVARIB) stock?
The P/E (price-to-earnings) ratio of Godavari Biorefineries Ltd (GODAVARIB) is -52.17. The P/B (price-to-book) ratio is 1.56.Which sector does Godavari Biorefineries Ltd (GODAVARIB) belong to?
Godavari Biorefineries Ltd (GODAVARIB) belongs to the Materials sector & Diversified Chemicals sub-sector.How to buy Godavari Biorefineries Ltd (GODAVARIB) shares?
You can directly buy Godavari Biorefineries Ltd (GODAVARIB) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Godavari Biorefineries Ltd
GODAVARIB Share Price
237.500.57% (-1.36)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
GODAVARIB Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
GODAVARIB Performance & Key Metrics
GODAVARIB Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 60.82 | 1.56 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 27.82 | 3.18 | 1.63% |
GODAVARIB Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
GODAVARIB Company Profile
Godavari Biorefineries Ltd is an ethanol-based chemical manufacturer with a diversified portfolio, including bio-based chemicals, sugar, ethanol, and power.
PIDILITIND
PE Ratio
72.78
72.78
1Y Return
7.34%
7.34%
Buy Reco %
72.22
72.22
SRF
PE Ratio
67.31
67.31
1Y Return
21.70%
21.70%
Buy Reco %
60.71
60.71
PIIND
PE Ratio
31.16
31.16
1Y Return
18.38%
18.38%
Buy Reco %
45.45
45.45
GODREJIND
PE Ratio
34.35
34.35
1Y Return
6.74%
6.74%
Buy Reco %
0.00
0.00
TATACHEM
PE Ratio
84.79
84.79
1Y Return
30.54%
30.54%
Buy Reco %
28.57
28.57
GODAVARIB Sentiment Analysis
GODAVARIB Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
GODAVARIB Stock Summary · November 2025
The company has demonstrated a robust recovery, reporting a 34% year-on-year revenue increase and a narrowing of EBITDA losses, driven by strategic initiatives in bio-based specialty chemicals and a return to profitability in ethanol operations. Despite these gains, challenges persist, particularly with stagnant ethanol prices and external market dynamics that could impact future profitability. The commitment to sustainability is evident through innovative projects like CO2 conversion to dimethyl ether, while advancements in drug discovery signal potential long-term growth in the biochemical segment. Additionally, the establishment of a grain-based ethanol facility aims to enhance resilience against market fluctuations, positioning the company favorably for future opportunities in both the energy and pharmaceutical sectors.
GODAVARIB Stock Growth Drivers
GODAVARIB Stock Growth Drivers
6Financial Recovery and Performance Improvement
Godavari Biorefineries Limited has reported a significant recovery in its financial performance, with revenue from
Strategic Initiatives and Innovations
The company is advancing its strategic initiatives, including the commissioning of a 200-kilo litres per
GODAVARIB Stock Challenges
GODAVARIB Stock Challenges
2Increased Operating Costs Due to Competitive Pressure
The company has faced increased operating costs as a result of neighboring mills adjusting their
Uncertainty in Future Cost Management
There are concerns regarding the potential for ongoing competition to lead to further increases in
GODAVARIB Forecast
GODAVARIB Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
GODAVARIB
GODAVARIB
Income
Balance Sheet
Cash Flow
Annual Normal View
GODAVARIB Income Statement
GODAVARIB Income Statement
Annual Normal View
| Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,472.80 | 1,546.38 | 1,709.98 | 2,023.08 | 1,701.07 | 1,886.91 | 2,007.83 | |||||||
Raw Materials | 889.68 | 1,094.93 | 1,230.02 | 1,323.70 | 1,545.46 | 1,260.55 | 1,871.08 | |||||||
| Power & Fuel Cost | 78.75 | 83.79 | 99.74 | 146.16 | 80.13 | 71.74 | ||||||||
| Employee Cost | 79.13 | 79.46 | 93.28 | 109.96 | 110.94 | 117.02 | ||||||||
| Selling & Administrative Expenses | 56.13 | 74.59 | 89.28 | 119.83 | 85.56 | 90.76 | ||||||||
| Operating & Other expenses | 252.14 | 47.79 | 57.12 | 168.81 | -268.96 | 226.54 | ||||||||
EBITDA | 116.97 | 165.82 | 140.54 | 154.62 | 147.94 | 120.30 | 136.75 | |||||||
| Depreciation/Amortization | 44.95 | 47.13 | 48.03 | 50.08 | 59.93 | 50.06 | 52.20 | |||||||
| PBIT | 72.02 | 118.69 | 92.51 | 104.54 | 88.01 | 70.24 | 84.55 | |||||||
| Interest & Other Items | 68.74 | 72.38 | 60.44 | 72.79 | 75.56 | 71.79 | 59.54 | |||||||
| PBT | 3.28 | 46.31 | 32.07 | 31.75 | 12.45 | -1.55 | 25.01 | |||||||
| Taxes & Other Items | -0.78 | 19.17 | 12.97 | 12.12 | 0.15 | 21.88 | 4.91 | |||||||
| Net Income | 4.06 | 27.14 | 19.10 | 19.63 | 12.30 | -23.43 | 20.10 | |||||||
| EPS | 0.97 | 6.47 | 4.55 | 4.68 | 2.93 | -5.03 | 3.93 | |||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
GODAVARIB Company Updates
FY 2026FY 2026
Investor Presentation
Nov 13PDF
Aug 10PDF
GODAVARIB Stock Peers
GODAVARIB Past Performance & Peer Comparison
GODAVARIB Past Performance & Peer Comparison
Comparing 3 stocks from
MaterialsDiversified Chemicals
Compare valuation on Screener
MaterialsDiversified Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Godavari Biorefineries Ltd | -52.17 | 1.56 | — |
| Pidilite Industries Ltd | 72.78 | 15.17 | 0.67% |
| SRF Ltd | 67.31 | 6.67 | 0.25% |
| PI Industries Ltd | 31.16 | 5.09 | 0.47% |
GODAVARIB Stock Price Comparison
Compare GODAVARIB with any stock or ETFCompare GODAVARIB with any stock or ETF
GODAVARIB
GODAVARIB Holdings
GODAVARIB Shareholdings
GODAVARIB Promoter Holdings Trend
GODAVARIB Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
GODAVARIB Institutional Holdings Trend
GODAVARIB Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
GODAVARIB Shareholding Pattern
GODAVARIB Shareholding Pattern
GODAVARIB Shareholding History
GODAVARIB Shareholding History
Foreign Institutions
Mutual Funds Invested in GODAVARIB
Mutual Funds Invested in GODAVARIB
No mutual funds holding trends are available
Top 5 Mutual Funds holding Godavari Biorefineries Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 4.3394% | Percentage of the fund’s portfolio invested in the stock 0.46% | Change in the portfolio weight of the stock over the last 3 months -0.06% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 75/96 (-6) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.2873% | Percentage of the fund’s portfolio invested in the stock 0.32% | Change in the portfolio weight of the stock over the last 3 months -0.08% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 45/53 (-7) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0000% | Percentage of the fund’s portfolio invested in the stock 0.00% | Change in the portfolio weight of the stock over the last 3 months -0.87% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 0/75 (0) |
Compare 3-month MF holding change on Screener
smallcases containing GODAVARIB stock
smallcases containing GODAVARIB stock
Looks like this stock is not in any smallcase yet.
GODAVARIB Events
GODAVARIB Events
GODAVARIB Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
GODAVARIB has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
GODAVARIB Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
GODAVARIB has not given any dividends in last 5 years
GODAVARIB Dividends
GODAVARIB Dividends
Hmm, looks like data is unavailable here. Please come back after some timeGODAVARIB Stock News & Opinions
GODAVARIB Stock News & Opinions
Articles & Videos
Earnings
Godavari Biorefineries reports consolidated net loss of Rs 41.59 crore in the September 2025 quarter
Net Loss of Godavari Biorefineries reported to Rs 41.59 crore in the quarter ended September 2025 as against net loss of Rs 75.00 crore during the previous quarter ended September 2024. Sales rose 34.21% to Rs 430.75 crore in the quarter ended September 2025 as against Rs 320.95 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales430.75320.95 34 OPM %-1.84-10.16 - PBDT-16.72-51.81 68 PBT-30.24-64.11 53 NP-41.59-75.00 45 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Godavari Biorefineries unveils innovative process of CO2-TO-DME
Godavari Biorefineries (GBL) announced the launch of a groundbreaking pilot project that transforms greenhouse gases into a sustainable, clean fuel. This revolutionary technology converts industrial CO2 emissions directly into Dimethyl Ether (DME) ' a low-emission, eco-friendly energy carrier. Dimethyl ether (DME) is a clean-burning fuel that can effectively replace conventional energy sources such as liquefied petroleum gas (LPG) and diesel, contributing to reduced emissions, improved environmental performance and decarbonisation. In addition to its role as a fuel, DME serves as a versatile chemical feedstock, supporting a wide range of industrial applications and chemical synthesis processes. The company has partnered with the renowned Institute of Chemical Technology, Mumbai (ICT) to develop this innovative process, which addresses the urgent need to reduce greenhouse gases and create value from waste.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Godavari Biorefineries schedules board meeting
Godavari Biorefineries will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
Godavari Biorefineries rallies after securing European patent for anti-cancer compounds
The patent, filed under its anti-cancer research segment, covers new chemical compounds that target cancer stem cells. These compounds have shown strong potential in treating cancers such as breast and prostate. The development strengthens the company's research portfolio and marks a step forward in its efforts toward high-value therapeutic innovation. Godavari Biorefineries is a leading integrated biorefinery specializing in bio-based chemicals, ethanol, and sugar & power production. The company one of the larger producers of ethanol and a pioneer in manufacturing ethanol-based chemicals in India. The company operates cutting-edge facilities in Sakarwadi, Maharashtra, and Sameerwadi, Karnataka and three advanced R&D facilities in Mumbai and plant locations. On a consolidated basis, Godavari Biorefineries reported net loss of Rs 16.02 crore in Q1 June 2025 as against net loss of Rs 26.11 crore in Q1 June 2024. Net sales rose 2.05% YoY to Rs 533.24 crore in Q1 June 2025. Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Godavari Biorefineries to hold AGM
Godavari Biorefineries announced that the 70th Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Godavari Biorefineries reports consolidated net loss of Rs 16.02 crore in the June 2025 quarter
Net Loss of Godavari Biorefineries reported to Rs 16.02 crore in the quarter ended June 2025 as against net loss of Rs 26.11 crore during the previous quarter ended June 2024. Sales rose 2.05% to Rs 533.24 crore in the quarter ended June 2025 as against Rs 522.53 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales533.24522.53 2 OPM %1.08-2.34 - PBDT-8.80-29.06 70 PBT-22.30-41.64 46 NP-16.02-26.11 39 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Godavari Biorefineries to convene board meeting
Godavari Biorefineries will hold a meeting of the Board of Directors of the Company on 7 August 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Godavari Biorefineries' anti-cancer patent now validated in Spain and the UK
Godavari Biorefineries announced that its European patent for a novel anti-cancer molecule has been validated in Spain, the United Kingdom, and as a Unitary Patent covering multiple EU member states. This milestone underscores the company's growing presence in high-impact scientific innovation, led by its dedicated Anti-Cancer Research Segment. The patented molecule has demonstrated efficacy against both cancer cells and cancer stem cells, marking a promising advance toward more targeted and effective cancer therapies. It has shown potential in the treatment of various cancers, including breast and prostate cancer, with encouraging efficacy and safety profiles in preclinical animal studies. The molecule is currently in Phase 1a clinical trials to assess safety in human patients with advanced solid tumors as well as in healthy volunteers. Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Godavari Biorefineries consolidated net profit rises 10.37% in the March 2025 quarter
Net profit of Godavari Biorefineries rose 10.37% to Rs 71.93 crore in the quarter ended March 2025 as against Rs 65.17 crore during the previous quarter ended March 2024. Sales declined 5.80% to Rs 579.50 crore in the quarter ended March 2025 as against Rs 615.19 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 23.41 crore in the year ended March 2025 as against net profit of Rs 12.30 crore during the previous year ended March 2024. Sales rose 10.88% to Rs 1870.25 crore in the year ended March 2025 as against Rs 1686.67 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales579.50615.19 -6 1870.251686.67 11 OPM %19.4018.50 -5.547.92 - PBDT108.58104.87 4 48.5272.37 -33 PBT95.7490.98 5 -1.5412.45 PL NP71.9365.17 10 -23.4112.30 PL Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Godavari Biorefineries to convene board meeting
Godavari Biorefineries will hold a meeting of the Board of Directors of the Company on 24 May 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 5.08%, vs industry avg of 9.36%
Over the last 5 years, market share decreased from 2.23% to 1.58%